App-Quantinova.ai

CIGARETTE SMOKING AND COFFEE CONSUMPTION INDEPENDENTLY INFLUENCE THE RISK OF DEVELOPING CARDIOVASCULAR DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS

J. Amaya-Amaya - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

ASSOCIATION BETWEEN ARTERIAL STIFFNESS AND PULMONARY ARTERIAL HYPERTENSION IN SYSTEMIC LUPUS ERYTHEMATOSUS

J. H. Lee - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

ANTIBODY TO DSDNA (ANTI-DSDNA), CIRCULATING IMMUNE COMPLEX (CIC) IN SYSTEMIC LUPUS ERITHEMATOSUS (SLE) AND ANTIPHOSPHOLIPID SYNDROME (APS)

T. Reshetnyak - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

PLASMA LEVELS OF PF-4VAR/CXCL4L1, A NONALLELIC VARIANT OF PLATELET FACTOR-4 (PF-4/CXCL4), ARE ELEVATED IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS)

M. P. Sikara - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

DIFFERENTIAL EXPRESSION OF MICRORNAS IN MONOCYTES AND NEUTROPHILS FROM PRIMARY ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS. POTENTIAL VALUE AS BIOMARKERS OF ATHEROTHROMBOTIC DISEASE

C. Perez-Sanchez - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

miR155

RITUXIMAB IN CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME: A POTENTIAL THERAPEUTIC OPTION

H. Berman - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Glucocorticoid

ULTRASOUND IN TRAUMA - WHAT THE RHEUMATOLOGIST NEEDS TO KNOW

S. Bianchi - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

EVALUATION OF ASYMPTOMATIC VENOUS DISEASE BY VENOUS DOPPLER ULTRASONOGRAPHY IN PATIENTS WITH BEHCE-S DISEASE WITHOUT OVERT THROMBOSIS

F. Alibaz-Oner - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

LONG TERM SUCCESSFUL RESULTS OF MEDICAL (STEROID, CYCLOPHOSPHAMIDE WITH/WITHOUT INTERFERON ALPHA) AND/OR ENDOVASCULAR INTERVENTION FOR ANEURYSM OF BEHCET DISEASE

U. Kalyoncu - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Venous thrombosis

Cyclophosphamide

VENOUS CLAUDICATION IS A SEVERE AND FREQUENT SYMPTOM IN BEHCE-S SYNDROME

S. Ugurlu - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

BEHCE-S DISEASE: IS THERE AN ASSOCIATION BETWEEN GENDER AND SEVERITY?

F. Izmailova - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Venous thrombosis

N/A

CLINICAL MANIFESTATIONS OF VASCULAR BEHCE-S DISEASE COMPLICATED WITH PULMONARY THROMBOEMBOLISM

H. Kikuchi - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Colchicine

CLINICAL FEATURES OF BEHCE-S DISEASE IN TUNISIAN PEOPLE

I. Cherif - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Venous thrombosis

N/A

ANCA-POSITIVE VASCULITIS IN SYSTEMIC SCLEROSIS: A TERTIARY REFERRAL CENTE-S EXPERIENCE

L. Damian - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Methylprednisolone

CEREBRAL ARTERITIS AND VASCULOGENIC RECURRENT BRAIN NECROSIS IN RHEUMATOID ARTHRITIS

M. Bely - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

GRANULOMATOSIS WITH POLYANGIITIS (GPA, WEGENE-S): COMPLICATIONS AND CAUSES OF DEATH

O. Zimba - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

CAUSES OF HOSPITALISATION IN BEHCE-S SYNDROME OVER A TEN-YEAR PERIOD

Y. Ozguler - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

OBESITY AND THE PREDICTION OF THE MINIMAL DISEASE ACTIVITY. A PROSPECTIVE STUDY IN PSORIATIC ARTHRITIS PATIENTS

M.N.D. Di Minno - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

TLR4 AND VEGF POLYMORPHISMS IN CHRONIC PERIAORTITIS

F. Atzeni - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

APOER2 AS A MEDIATOR OF THE ANTIPHOSPHOLIPID SYNDROME

C. Mineo - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Nitric oxide

Filters

7277 Abstracts